M12.25
Villonodular synovitis (pigmented), hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Villonodular synovitis, particularly pigmented villonodular synovitis (PVNS), is a rare joint disorder characterized by abnormal growth of the synovial membrane—the lining of the joint capsule. When it affects the hip, it can cause pain, swelling, and limited movement. While PVNS can occur in various joints, its manifestation in the hip is less common but may lead to significant joint problems if left untreated.
Causes & Symptoms
Clinical Causes: In most cases, the exact cause of pigmented villonodular synovitis remains unknown. It is believed to result from an abnormal proliferation of synovial cells, possibly linked to inflammation or a neoplastic process. Some theories suggest that PVNS might be related to a genetic or immune response, but conclusive evidence is lacking. Trauma or joint injury has occasionally been considered as a contributing factor, though no definitive link has been established.
Key Symptoms: Persistent or recurrent joint pain, often described as aching or throbbing. Swelling in the groin or thigh area around the hip joint. Reduced range of motion, making it difficult to perform daily activities or move the hip freely. A sensation of catching or locking in the joint during movement. Occasional warmth or tenderness over the affected joint. In advanced cases, joint stiffness and difficulty bearing weight.
Diagnostic & Treatment
Diagnosis Path: Physical examination to assess joint swelling, tenderness, and range of motion. Imaging studies such as magnetic resonance imaging (MRI) are crucial, revealing characteristic signs like localized or diffuse synovial thickening and hemosiderin deposits, which give a pigmented appearance. X-rays may show joint space narrowing or bone erosion in advanced cases. Biopsy of the synovial tissue can confirm the diagnosis by identifying characteristic histopathological features, including synovial proliferation and hemosiderin deposits.
Treatment Protocols: Synovectomy, the surgical removal of the affected synovial tissue, is the main treatment method. Open or arthroscopic surgical techniques may be employed depending on the extent of the condition. In some cases, radiotherapy might be considered post-surgery to reduce the risk of recurrence. Physical therapy can help restore joint function and strengthen surrounding muscles after surgery. Long-term monitoring is essential to identify any signs of recurrence early.
Clinical Advice & FAQs
Billing Guidance
Is M12.25 a billable ICD-10 code?
Yes, M12.25 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M12.25?
Clinical documentation must specify the nature of Villonodular synovitis (pigmented), hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
